MA 醫(yī)學(xué)顧問-腫瘤診斷
職位描述
Medical & Scientific leadership for internal stakeholdersTo establish AstraZeneca as a scientific leader through proactive, updated and effective Medical input?Develop and implement the local medical plan to address unmet medical needs in priority disease areas and ensure alignment with the brand plan. ?Provide medical input for the development of company’s Brand plans ?Provide the AZ internal stakeholders with an understanding of the local medical community, clinical practice, trends and real or perceived gaps in current scientific knowledge and medical treatment, competitive intelligence ?Develop and implement pre-launch medical plan/activities for new products at least 2 years prior to the planned launch in the country to address key clinical and scientific challenges?Provide medical leadership on faculty and content development for medical programmes including national congresses, advisory boards, scientific exchange meetings, publications, CMEs to meet identified needs?Provide medical input to global protocols, study feasibility and local customer’s research initiatives.Quantity?% of trainings conducted versus planQuality?Feedback from participants?Feedback from business partners on quality of contribution to Medical and Brand plans –collected by line manager?Feedback on congress report/highlights shared with cross-functional team as planned – completed feedback templatesProvide medical input into the Life Cycle Management of priority brands and TAs to meet unmet medical needs?Participate as key member of brand team as strategic partner towards LCM actions ?Develop NIS or registry studies to address unmet medical needs ?Initiate discussions with customers to develop studies that will fulfill global and local business strategies. ?ESR Proposals- Number?For NIS number of sites, KEEs, investigators involved in studies versus plan?Timely publications of studies completedGovernance and ensuring overall adherence to processes and regulation?Provide medical input to the creation, development and agreement of promotional material and ensure all material is in line with internal SOPs and meets IFPMA code ?Support Clinical team to select appropriate investigators and sites optimising quality, delivery and commercial benefit ?Ensures compliance with AZ code of conduct, Corporate Governance, Audits requirement, guidelines, codes, policies and procedures ?Ensures that company confidentiality is maintained (i.e. intellectual property, product, strategic and salary information) ?Discloses potential breach of codes or conducts?Display behaviours consistent with the AZ vision and values (those with line report, their team members demonstrates the same)?Feedback from others?No valid complaints from competitors against marketing practice?No breach of confidentiality. All disclosureExternal Medical & Scientific engagementBuild, enhance and maintain the engagement with key external expertise (KEE). ?Proactively identify HCPs with high levels of scientific expertise in local treatment practice to collaborate on specific medical marketing activities ?Development and implementation of KEE engagement plan in collaboration with line manager. ?Develop database of KEEs and also provide recommendations for advisory board participation, potential speakers and train speakers as appropriate. ?Develop own scientific knowledge and share emerging data with HCPs, discussing all aspects of the data in a scientific, objective and balanced way. Disseminate results of studies completed to medical community by translating their clinical values and incorporating into business strategies. ?Respond to unsolicited requests for information about unapproved AZ products or unapproved uses of approved products, presenting such information in an objective, scientifically balanced, substantiated manner.Quantity?Coverage of KEEs versus plan?No of Advisory Board Meetings versus plan?No of P2Ps/round table discussions versus plan?No of CMEs versus plan?Improvement in advocacy score as reviewed by line manager1:1Quality?Meeting skills and presentation skills based on in field coaching and annual assessment – use standard assessment form?Positive customer feedback post eventsDevelop or initiate scientific programs to explore unmet medical needs in priority disease area(s)?Discuss potential involvement in ESR and RWEs. Interact in the field with KEEs for clinical trials, ESRs ?Able to conduct discussions on clinical trials in terms of study design and feasibilityQuantity?No of study communicatedQuality?Customer feedback?In field observation by line managerDevelopmentContinuously demonstrate development of scientific expertise in disease area(s) of company focus??Positive engagement and response to coaching and feedback received from line manager. ??In daily work takes time to reflect on customer interactions and works on areas agreed with line manager as priorities for development. ??Develop behaviours lead to enhanced effectiveness as outlined in Competency definitions. ??Proactively demonstrate the AZ Values ??Active participation in AZ training, projects, and meetings depending on development needsQuality?100% completion of training as required on Medical Academy?Assessment of knowledge on coaching visits and assessmentHas a personal development plan and completes identified development activities as plannedComplianceCompliance with relevant company and industry code of Conduct and also to comply with local country codes?Keep regular update and operate within the relevant Codes of Conduct, Ethical Interactions (EI), including GPEI and SOPs ?Be sure to understand AZ policies when engage to KEEs and external stakeholders?100% adherence to compliance
企業(yè)簡介
阿斯利康是全球領(lǐng)先制藥公司,由前瑞典阿斯特拉公司和前英國捷利康公司于1999年合并而成。阿斯利康在6大治療領(lǐng)域?yàn)榛颊咛峁└挥趧?chuàng)新,卓有成效的醫(yī)藥產(chǎn)品,包括消化、心血管、腫瘤、中樞神經(jīng)、麻醉和呼吸等,其中許多產(chǎn)品居于世界領(lǐng)先地位。
阿斯利康總部位于英國倫敦,研發(fā)總部位于瑞典。產(chǎn)品銷售覆蓋全球100多個(gè)國家和地區(qū)。2005年公司銷售收入為240億美元。
阿斯利康擁有強(qiáng)大的研發(fā)能力,平均每個(gè)工作日的研發(fā)投入達(dá)到1400萬美元 (2005年研發(fā)總投入為34億美元)。我們?cè)?個(gè)國家設(shè)有11個(gè)研發(fā)機(jī)構(gòu),共有11,900名員工從事與新藥研發(fā)相關(guān)的工作。
阿斯利康擁有極具希望的早期開發(fā)產(chǎn)品組合,共有45個(gè)項(xiàng)目處于臨床前研究階段、17個(gè)項(xiàng)目處于一期臨床研究階段、13個(gè)項(xiàng)目處于二期臨床研究階段、6個(gè)項(xiàng)目處于三期臨床研究階段。
阿斯利康在全球19個(gè)國家有27個(gè)生產(chǎn)基地,共有14,000名員工致力于為客戶提供安全、有效、高質(zhì)量的產(chǎn)品。
阿斯利康在全球共有65,000名員工,從事醫(yī)藥產(chǎn)品和醫(yī)療服務(wù)的研發(fā)、生產(chǎn)和銷售業(yè)務(wù)。
阿斯利康被列入道瓊斯可持續(xù)發(fā)展指數(shù)(全球)以及顯示企業(yè)良好社會(huì)責(zé)任度的富時(shí)社會(huì)責(zé)任指數(shù)(FTSE4Good Index)。
職位發(fā)布企業(yè)

阿斯利康制藥公司
企業(yè)性質(zhì):
企業(yè)規(guī)模:1-49人
成立年份:
企業(yè)網(wǎng)址:http://www.chnequestrian.com
企業(yè)地址:海淀區(qū)
該企業(yè)其他職位更多>>
相關(guān)職位推薦
上海相關(guān)職位: 耗材市場經(jīng)理 市場經(jīng)理(耗材) 集采線項(xiàng)目經(jīng)理 產(chǎn)品經(jīng)理 醫(yī)學(xué)聯(lián)絡(luò)官(MSL) 醫(yī)學(xué)經(jīng)理 醫(yī)藥代表-輔助生殖 輔助生殖醫(yī)藥代表 醫(yī)藥大區(qū)經(jīng)理 學(xué)術(shù)推廣經(jīng)理
熱門區(qū)域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
上海招聘企業(yè): 易葫蘆(上海)醫(yī)藥科技有限公司 百進(jìn)冠合(海南) 醫(yī)療科技有限公司 上海華茂藥業(yè)有限公司 上海信誼藥廠有限公司 上海強(qiáng)生制藥 歐姆龍健康醫(yī)療(中國)有限公司 青海瑞成藥業(yè)(集團(tuán))有限公司 上海交通大學(xué)醫(yī)學(xué)院附屬瑞金醫(yī)院 復(fù)旦大學(xué)附屬中山醫(yī)院 上海復(fù)星醫(yī)藥
職位發(fā)布日期: 2025-03-31